{"id":47109,"date":"2017-08-14T12:39:00","date_gmt":"2017-08-14T11:39:00","guid":{"rendered":"https:\/\/wncen.com\/?p=47109"},"modified":"2019-09-30T11:45:39","modified_gmt":"2019-09-30T11:45:39","slug":"ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing","status":"publish","type":"post","link":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","title":{"rendered":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain"},"content":{"rendered":"<p><em>\u00a0<\/em><em>Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale<\/em><\/p>\n<p><strong>Zug, Switzerland and Boston, MA &#8212; August 11, 2017 &#8212;<a href=\"http:\/\/www.ambrosus.com\" rel=\"nofollow\"> Ambrosus<\/a><\/strong>, the world\u2019s first trusted blockchain-based ecosystem for the supply chain, today announced a partnership with pharmaceutical pioneer Trek Therapeutics, PBC (Trek) to apply integrated sensors coupled with blockchain-based technology to pharmaceutical drug manufacturing in Trek\u2019s clinical development program. This announcement comes as blockchain industry heavyweight Jaron Lukasiewicz joins Ambrosus as Strategic Advisor.<\/p>\n<p>Combining high-tech sensors, blockchain, and powered by smart contracts, Ambrosus is building the world\u2019s first publicly-verifiable, community-driven ecosystem to ensure the quality, safety, and origins of essential products, such as medicine, food and commodities. As part of the collaboration, Ambrosus will conduct pilot projects with Trek to monitor the quality, safety and integrity of all stages of the pharmaceutical manufacturing process.<\/p>\n<p>Trek Co-founder and CEO Dr. Ann Kwong said, \u201cCurrently the pharmaceutical manufacturing process is highly regulated by pharmaceutical manufacturers and by regulatory authorities in an extremely labor-intensive and expensive manner. We hope to partner with Ambrosus to create a continuous monitoring and tracking system that will be less labor intensive, less expensive, and more transparent to all parties with a stake in quality pharmaceutical manufacturing.\u00a0 Our goal is to develop a system that is robust enough that Trek can submit data to support our manufacturing application for regulatory approval of our drugs from the FDA and EMA authorities.\u201d<\/p>\n<p>\u201cAdditionally, patients currently have no way to ascertain the quality of the medicines they ingest. Trek believes it is important to be able to demonstrate to patients that while our drugs are affordable, they\u2019re also of the highest quality,\u201d Dr Kwong added.<\/p>\n<p>Ambrosus Co-Founder and CEO Angel Versetti said, \u201cFollowing the successful implementation of the Ambrosus protocol in global food supply chains, we are delighted to now apply our blockchain protocol to help ensure the quality, safety and integrity of another vitally important product \u2013 pharmaceuticals.\u201d<\/p>\n<p><a href=\"http:\/\/trektx.com\/\" rel=\"nofollow\">Trek Therapeutics<\/a>, PBC is a privately-held, public-benefit corporation developing treatments for serious infections. Its mission is to provide cost-effective, affordable, and accessible medicines to treat patients that suffer from infectious diseases and commercialize them for global populations. Since the company\u2019s founding in 2014, Trek has raised US$10M in Series A funding. Trek\u2019s management team and board of directors is comprised of seasoned drug-development executives from Vertex, Schering Plough\/Merck, Pharmasset\/Gilead, Bristol-Myers Squibb, Roche, Celgene Global Health, Idenix, and Genzyme.<\/p>\n<p>\u201cTrek is focused on developing safe, novel medicines for infectious diseases at affordable and accessible prices. The pharmaceutical supply chain encompasses many phases and a multitude of stakeholders, requiring responsible parties to seek new methods of guaranteeing the quality and integrity of critical products. As Trek continues their mission to develop pharmaceuticals for budget-constrained patients across North America and Europe, our partnership will help to develop protocols to provide transparency and quality assurance during each phase of the process,\u201d added Versetti.<\/p>\n<p>As part of the pilot projects, Ambrosus\u2019s protocol will work to verify and track the entire manufacturing chain from the primary chemical starting materials through multiple steps of synthesis, purification, and verification of the active pharmaceutical ingredient (API); followed by formulation of the API into drug product; packaging, labeling, storage, and shipping to clinical trial sites.<\/p>\n<p>\u201cBacked by a superb core team of developers, advisors, and researchers, Ambrosus\u2019 protocol will provide the transparency necessary in our manufacturing process to help ensure the integrity of supply chains. With our commitment to providing affordable high quality medicine, we believe this partnership could revolutionize the pharmaceutical industry quality control of manufacturing at every stage from plant to patient,\u201d Dr. Kwong said.<\/p>\n<p>Joining the Ambrosus team as an Advisor is blockchain luminary Jaron Lukasiewicz. Speaking on the announcement, Versetti added: \u201cAmbrosus is excited to welcome Jaron Lukasiewicz as our Strategic Advisor. As a highly-respected blockchain industry figure we are eager to utilize his invaluable expertise as we lead up to our September token sale and beyond.\u201d<\/p>\n<p>Jaron\u00a0 Lukasiewicz\u00a0 has\u00a0 been\u00a0 a\u00a0 notable\u00a0 bitcoin\u00a0 and\u00a0 blockchain industry\u00a0 figurehead\u00a0 since\u00a0 2012. Lukasiewicz\u00a0 founded\u00a0 and\u00a0 served\u00a0 as\u00a0 CEO\u00a0 of\u00a0 Coinsetter,\u00a0 a\u00a0 New\u00a0 York\u00a0 City-based\u00a0 bitcoin exchange,\u00a0 which\u00a0 was\u00a0 acquired\u00a0 by\u00a0 Kraken,\u00a0 the\u00a0 world\u2019s\u00a0 largest\u00a0 digital\u00a0 asset\u00a0 exchange\u00a0 in\u00a0 Euro volume,\u00a0 in\u00a0 January\u00a0 2016.\u00a0 The\u00a0 sale\u00a0 was,\u00a0 at\u00a0 the\u00a0 time,\u00a0 the\u00a0 largest\u00a0 M&amp;A\u00a0 deal\u00a0 in\u00a0 bitcoin\u00a0 history. Lukasiewicz\u00a0 also\u00a0 served\u00a0 as\u00a0 CEO\u00a0 of\u00a0 Cavirtex\u00a0 (Canadian\u00a0 Virtual\u00a0 Exchange),\u00a0 the\u00a0 oldest\u00a0 and largest\u00a0 Canadian\u00a0 bitcoin\u00a0 exchange,\u00a0 which\u00a0 was\u00a0 also\u00a0 acquired\u00a0 by\u00a0 Kraken\u00a0 in\u00a0 2016.\u00a0 Since\u00a0 the acquisition, Lukasiewicz has served as an active advisor to several blockchain companies and blockchain investment funds in addition to his role as the CEO of WRKFLOW.<\/p>\n<p>Jaron Lukasiewicz said: \u201cI am excited about the future of the Ambrosus project and equally the team\u00a0 behind\u00a0 it,\u00a0 who\u00a0 together\u00a0 carries\u00a0 decades\u00a0 of experience\u00a0 in\u00a0 their\u00a0 target\u00a0 markets.\u00a0 Ambrosus can\u00a0 become\u00a0 a\u00a0 fundamental\u00a0 technology\u00a0 utilized\u00a0 in\u00a0 sectors ranging from\u00a0 food\u00a0 to\u00a0 pharma, stretching\u00a0 the\u00a0\u00a0 boundaries of what\u00a0 blockchain\u00a0 technology\u00a0\u00a0 can\u00a0\u00a0 accomplish\u00a0\u00a0 in\u00a0\u00a0 real world applications.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About Ambrosus:<\/strong><\/p>\n<p>Founded in 2016 by Angel Versetti and Dr Stefan Meyer, Ambrosus is the world\u2019s first publicly-verifiable and community-driven system to assure the quality, safety, and origins of products such as food and pharmaceuticals. Officially endorsed by SQS (Swiss Quality and Safety Association), Ambrosus boasts the support of significant global bodies and associations including the United Nations,<a href=\"https:\/\/www.epfl.ch\/index.en.html\" rel=\"nofollow\"> EPFL<\/a>, the Crypto Valley Association, and financial backing from the Government of the Canton of Vaud, Switzerland.<\/p>\n<p>With an underlying ERC20-standard token called Amber, Ambrosus will complete a tokensale in September 2017 that will serve to fuel the development of the Ambrosus ecosystem.<\/p>\n<p>For more information, or to see technical papers for Ambrosus sensors, marketplace and non invasive analytics, visit<a href=\"http:\/\/www.ambrosus.com\" rel=\"nofollow\"> www.ambrosus.com<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About Trek:<\/strong><\/p>\n<p>Trek Therapeutics, PBC is a private, clinical stage public benefit corporation developing treatments for serious infections. Its mission is to profitably develop affordable and accessible medicines to treat infectious diseases and to commercialize them for global populations starting with hepatitis C virus (HCV) infection. Its commercial strategy is to price their treatment regimen low enough to include the majority of patients infected with HCV who cannot afford the expensive treatments available today. Trek is currently raising Series B financing to support the completion of its Phase 2a program and initiate its Phase 2b studies.\u00a0 Trek is examining the possibility of a listing on the Euronext Growth and other markets. For further information, please visit <a href=\"http:\/\/www.trektx.com\/\" rel=\"nofollow\">http:\/\/www.trektx.com\/<\/a>.<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Media Contact:<\/strong><\/p>\n<p>Lawrence Chiu<\/p>\n<p>Marketing Assistant<\/p>\n<p>TokenMarket Ltd.<\/p>\n<p><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA &#8212; August 11, 2017 &#8212; Ambrosus, the world\u2019s first trusted blockchain-based ecosystem for the supply chain, today announced a partnership with pharmaceutical pioneer Trek Therapeutics, PBC (Trek) to apply integrated sensors coupled with blockchain-based technology to pharmaceutical drug manufacturing in Trek\u2019s clinical development program. This announcement comes as blockchain industry heavyweight Jaron Lukasiewicz joins Ambrosus as Strategic Advisor. Combining high-tech sensors, blockchain, and powered by smart contracts, Ambrosus is building the world\u2019s first publicly-verifiable, community-driven ecosystem to ensure the quality, safety, and origins of essential products, such as medicine, food and commodities. As part of the collaboration, Ambrosus will conduct pilot projects with Trek to monitor the quality, safety and integrity of all stages of the pharmaceutical manufacturing process. Trek Co-founder and CEO Dr. Ann Kwong said, \u201cCurrently the pharmaceutical manufacturing process is highly regulated by pharmaceutical manufacturers and by regulatory authorities in an extremely labor-intensive and expensive manner. We hope to partner with Ambrosus to create a continuous monitoring and tracking system that will be less labor intensive, less expensive, and more transparent to all parties with a stake in quality pharmaceutical manufacturing.\u00a0 Our goal is to develop a system that is robust enough that Trek can submit data to support our manufacturing application for regulatory approval of our drugs from the FDA and EMA authorities.\u201d \u201cAdditionally, patients currently have no way to ascertain the quality of the medicines they ingest. Trek believes it is important to be able to demonstrate to patients that while our drugs are affordable, they\u2019re also of the highest quality,\u201d Dr Kwong added. Ambrosus Co-Founder and CEO Angel Versetti said, \u201cFollowing the successful implementation of the Ambrosus protocol in global food supply chains, we are delighted to now apply our blockchain protocol to help ensure the quality, safety and integrity of another vitally important product \u2013 pharmaceuticals.\u201d Trek Therapeutics, PBC is a privately-held, public-benefit corporation developing treatments for serious infections. Its mission is to provide cost-effective, affordable, and accessible medicines to treat patients that suffer from infectious diseases and commercialize them for global populations. Since the company\u2019s founding in 2014, Trek has raised US$10M in Series A funding. Trek\u2019s management team and board of directors is comprised of seasoned drug-development executives from Vertex, Schering Plough\/Merck, Pharmasset\/Gilead, Bristol-Myers Squibb, Roche, Celgene Global Health, Idenix, and Genzyme. \u201cTrek is focused on developing safe, novel medicines for infectious diseases at affordable and accessible prices. The pharmaceutical supply chain encompasses many phases and a multitude of stakeholders, requiring responsible parties to seek new methods of guaranteeing the quality and integrity of critical products. As Trek continues their mission to develop pharmaceuticals for budget-constrained patients across North America and Europe, our partnership will help to develop protocols to provide transparency and quality assurance during each phase of the process,\u201d added Versetti. As part of the pilot projects, Ambrosus\u2019s protocol will work to verify and track the entire manufacturing chain from the primary chemical starting materials through multiple steps of synthesis, purification, and verification of the active pharmaceutical ingredient (API); followed by formulation of the API into drug product; packaging, labeling, storage, and shipping to clinical trial sites. \u201cBacked by a superb core team of developers, advisors, and researchers, Ambrosus\u2019 protocol will provide the transparency necessary in our manufacturing process to help ensure the integrity of supply chains. With our commitment to providing affordable high quality medicine, we believe this partnership could revolutionize the pharmaceutical industry quality control of manufacturing at every stage from plant to patient,\u201d Dr. Kwong said. Joining the Ambrosus team as an Advisor is blockchain luminary Jaron Lukasiewicz. Speaking on the announcement, Versetti added: \u201cAmbrosus is excited to welcome Jaron Lukasiewicz as our Strategic Advisor. As a highly-respected blockchain industry figure we are eager to utilize his invaluable expertise as we lead up to our September token sale and beyond.\u201d Jaron\u00a0 Lukasiewicz\u00a0 has\u00a0 been\u00a0 a\u00a0 notable\u00a0 bitcoin\u00a0 and\u00a0 blockchain industry\u00a0 figurehead\u00a0 since\u00a0 2012. Lukasiewicz\u00a0 founded\u00a0 and\u00a0 served\u00a0 as\u00a0 CEO\u00a0 of\u00a0 Coinsetter,\u00a0 a\u00a0 New\u00a0 York\u00a0 City-based\u00a0 bitcoin exchange,\u00a0 which\u00a0 was\u00a0 acquired\u00a0 by\u00a0 Kraken,\u00a0 the\u00a0 world\u2019s\u00a0 largest\u00a0 digital\u00a0 asset\u00a0 exchange\u00a0 in\u00a0 Euro volume,\u00a0 in\u00a0 January\u00a0 2016.\u00a0 The\u00a0 sale\u00a0 was,\u00a0 at\u00a0 the\u00a0 time,\u00a0 the\u00a0 largest\u00a0 M&amp;A\u00a0 deal\u00a0 in\u00a0 bitcoin\u00a0 history. Lukasiewicz\u00a0 also\u00a0 served\u00a0 as\u00a0 CEO\u00a0 of\u00a0 Cavirtex\u00a0 (Canadian\u00a0 Virtual\u00a0 Exchange),\u00a0 the\u00a0 oldest\u00a0 and largest\u00a0 Canadian\u00a0 bitcoin\u00a0 exchange,\u00a0 which\u00a0 was\u00a0 also\u00a0 acquired\u00a0 by\u00a0 Kraken\u00a0 in\u00a0 2016.\u00a0 Since\u00a0 the acquisition, Lukasiewicz has served as an active advisor to several blockchain companies and blockchain investment funds in addition to his role as the CEO of WRKFLOW. Jaron Lukasiewicz said: \u201cI am excited about the future of the Ambrosus project and equally the team\u00a0 behind\u00a0 it,\u00a0 who\u00a0 together\u00a0 carries\u00a0 decades\u00a0 of experience\u00a0 in\u00a0 their\u00a0 target\u00a0 markets.\u00a0 Ambrosus can\u00a0 become\u00a0 a\u00a0 fundamental\u00a0 technology\u00a0 utilized\u00a0 in\u00a0 sectors ranging from\u00a0 food\u00a0 to\u00a0 pharma, stretching\u00a0 the\u00a0\u00a0 boundaries of what\u00a0 blockchain\u00a0 technology\u00a0\u00a0 can\u00a0\u00a0 accomplish\u00a0\u00a0 in\u00a0\u00a0 real world applications.\u201d &nbsp; About Ambrosus: Founded in 2016 by Angel Versetti and Dr Stefan Meyer, Ambrosus is the world\u2019s first publicly-verifiable and community-driven system to assure the quality, safety, and origins of products such as food and pharmaceuticals. Officially endorsed by SQS (Swiss Quality and Safety Association), Ambrosus boasts the support of significant global bodies and associations including the United Nations, EPFL, the Crypto Valley Association, and financial backing from the Government of the Canton of Vaud, Switzerland. With an underlying ERC20-standard token called Amber, Ambrosus will complete a tokensale in September 2017 that will serve to fuel the development of the Ambrosus ecosystem. For more information, or to see technical papers for Ambrosus sensors, marketplace and non invasive analytics, visit www.ambrosus.com. &nbsp; About Trek: Trek Therapeutics, PBC is a private, clinical stage public benefit corporation developing treatments for serious infections. Its mission is to profitably develop affordable and accessible medicines to treat infectious diseases and to commercialize them for global populations starting with hepatitis C virus (HCV) infection. Its commercial strategy is to price their treatment regimen low enough to include the majority of patients infected with HCV who cannot afford the expensive treatments available today. Trek is currently raising Series B financing to support the completion of its Phase 2a program and initiate its Phase 2b studies.\u00a0 Trek is examining the possibility of a listing on the Euronext Growth and other markets. For further information, please visit http:\/\/www.trektx.com\/. \u00a0 Media Contact: Lawrence Chiu Marketing Assistant TokenMarket Ltd.  &nbsp;<\/p>\n","protected":false},"author":516,"featured_media":47204,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[17],"tags":[10734],"class_list":["post-47109","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sponsored","tag-ambrosus"],"acf":[],"yoast_head":"\n<title>AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain<\/title>\n<meta name=\"description\" content=\"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain\" \/>\n<meta property=\"og:description\" content=\"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"NewsBTC\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/newsbtc\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-14T11:39:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-30T11:45:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"newsbtc\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@newsbtc\" \/>\n<meta name=\"twitter:site\" content=\"@newsbtc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"newsbtc\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\"},\"author\":{\"name\":\"newsbtc\",\"@id\":\"https:\/\/wncen.com\/#\/schema\/person\/92359df06a75cfe67fe817215be85568\"},\"headline\":\"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain\",\"datePublished\":\"2017-08-14T11:39:00+00:00\",\"dateModified\":\"2019-09-30T11:45:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\"},\"wordCount\":1087,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/wncen.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500\",\"keywords\":[\"Ambrosus\"],\"articleSection\":[\"Sponsored\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#respond\"]}],\"copyrightYear\":\"2017\",\"copyrightHolder\":{\"@id\":\"https:\/\/wncen.com\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\",\"url\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\",\"name\":\"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain\",\"isPartOf\":{\"@id\":\"https:\/\/wncen.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500\",\"datePublished\":\"2017-08-14T11:39:00+00:00\",\"dateModified\":\"2019-09-30T11:45:39+00:00\",\"description\":\"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the\",\"breadcrumb\":{\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage\",\"url\":\"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500\",\"contentUrl\":\"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500\",\"width\":1500,\"height\":500,\"caption\":\"Ambrosus New Header\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/wncen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wncen.com\/#website\",\"url\":\"https:\/\/wncen.com\/\",\"name\":\"NewsBTC\",\"description\":\"Bitcoin &amp; Cryptocurrency News Today\",\"publisher\":{\"@id\":\"https:\/\/wncen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wncen.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wncen.com\/#organization\",\"name\":\"NewsBTC\",\"url\":\"https:\/\/wncen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/wncen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wncen.com\/wp-content\/uploads\/2020\/06\/logo-min.png?fit=157%2C46\",\"contentUrl\":\"https:\/\/wncen.com\/wp-content\/uploads\/2020\/06\/logo-min.png?fit=157%2C46\",\"width\":157,\"height\":46,\"caption\":\"NewsBTC\"},\"image\":{\"@id\":\"https:\/\/wncen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/newsbtc\",\"https:\/\/x.com\/newsbtc\",\"https:\/\/www.youtube.com\/channel\/UC9v9erBEru5y4c3FA0wehEw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/wncen.com\/#\/schema\/person\/92359df06a75cfe67fe817215be85568\",\"name\":\"newsbtc\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/wncen.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/94ab7b7d4fc97c1eba30a571a6d1348e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/94ab7b7d4fc97c1eba30a571a6d1348e?s=96&d=mm&r=g\",\"caption\":\"newsbtc\"},\"url\":\"https:\/\/wncen.com\/author\/newsbtc\/\"}]}<\/script>\n","yoast_head_json":{"title":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain","description":"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","og_locale":"en_US","og_type":"article","og_title":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain","og_description":"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the","og_url":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","og_site_name":"NewsBTC","article_publisher":"https:\/\/www.facebook.com\/newsbtc","article_published_time":"2017-08-14T11:39:00+00:00","article_modified_time":"2019-09-30T11:45:39+00:00","og_image":[{"width":1500,"height":500,"url":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg","type":"image\/jpeg"}],"author":"newsbtc","twitter_card":"summary_large_image","twitter_creator":"@newsbtc","twitter_site":"@newsbtc","twitter_misc":{"Written by":"newsbtc","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#article","isPartOf":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/"},"author":{"name":"newsbtc","@id":"https:\/\/wncen.com\/#\/schema\/person\/92359df06a75cfe67fe817215be85568"},"headline":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain","datePublished":"2017-08-14T11:39:00+00:00","dateModified":"2019-09-30T11:45:39+00:00","mainEntityOfPage":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/"},"wordCount":1087,"commentCount":0,"publisher":{"@id":"https:\/\/wncen.com\/#organization"},"image":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500","keywords":["Ambrosus"],"articleSection":["Sponsored"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#respond"]}],"copyrightYear":"2017","copyrightHolder":{"@id":"https:\/\/wncen.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","url":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","name":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain","isPartOf":{"@id":"https:\/\/wncen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage"},"image":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage"},"thumbnailUrl":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500","datePublished":"2017-08-14T11:39:00+00:00","dateModified":"2019-09-30T11:45:39+00:00","description":"\u00a0Jaron Lukasiewicz joins as Strategic Advisor in advance of September Token Sale Zug, Switzerland and Boston, MA -- August 11, 2017 -- Ambrosus, the","breadcrumb":{"@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#primaryimage","url":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500","contentUrl":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500","width":1500,"height":500,"caption":"Ambrosus New Header"},{"@type":"BreadcrumbList","@id":"https:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/wncen.com\/"},{"@type":"ListItem","position":2,"name":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain"}]},{"@type":"WebSite","@id":"https:\/\/wncen.com\/#website","url":"https:\/\/wncen.com\/","name":"NewsBTC","description":"Bitcoin &amp; Cryptocurrency News Today","publisher":{"@id":"https:\/\/wncen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wncen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/wncen.com\/#organization","name":"NewsBTC","url":"https:\/\/wncen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wncen.com\/#\/schema\/logo\/image\/","url":"https:\/\/wncen.com\/wp-content\/uploads\/2020\/06\/logo-min.png?fit=157%2C46","contentUrl":"https:\/\/wncen.com\/wp-content\/uploads\/2020\/06\/logo-min.png?fit=157%2C46","width":157,"height":46,"caption":"NewsBTC"},"image":{"@id":"https:\/\/wncen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/newsbtc","https:\/\/x.com\/newsbtc","https:\/\/www.youtube.com\/channel\/UC9v9erBEru5y4c3FA0wehEw"]},{"@type":"Person","@id":"https:\/\/wncen.com\/#\/schema\/person\/92359df06a75cfe67fe817215be85568","name":"newsbtc","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/wncen.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/94ab7b7d4fc97c1eba30a571a6d1348e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/94ab7b7d4fc97c1eba30a571a6d1348e?s=96&d=mm&r=g","caption":"newsbtc"},"url":"https:\/\/wncen.com\/author\/newsbtc\/"}]}},"parsely":{"version":"1.1.0","meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain","url":"http:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/wncen.com\/sponsored\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\/"},"thumbnailUrl":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?resize=200%2C200","image":{"@type":"ImageObject","url":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500"},"articleSection":"Sponsored","author":[{"@type":"Person","name":"newsbtc"}],"creator":["newsbtc"],"publisher":{"@type":"Organization","name":"NewsBTC","logo":"https:\/\/wncen.com\/wp-content\/uploads\/2020\/06\/cropped-cropped-cropped-favicon.png?w=32"},"keywords":["ambrosus"],"dateCreated":"2017-08-14T11:39:00Z","datePublished":"2017-08-14T11:39:00Z","dateModified":"2019-09-30T11:45:39Z"},"rendered":"<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"AMBROSUS Partners with TREK THERAPEUTICS to Develop a Blockchain\",\"url\":\"http:\\\/\\\/wncen.com\\\/sponsored\\\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/wncen.com\\\/sponsored\\\/ambrosus-partners-trek-therapeutics-develop-blockchain-powered-method-track-quality-pharmaceutical-manufacturing\\\/\"},\"thumbnailUrl\":\"https:\\\/\\\/wncen.com\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/Ambrosus-New-Header.jpg?resize=200%2C200\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/wncen.com\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/Ambrosus-New-Header.jpg?fit=1500%2C500\"},\"articleSection\":\"Sponsored\",\"author\":[{\"@type\":\"Person\",\"name\":\"newsbtc\"}],\"creator\":[\"newsbtc\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"NewsBTC\",\"logo\":\"https:\\\/\\\/wncen.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/cropped-cropped-cropped-favicon.png?w=32\"},\"keywords\":[\"ambrosus\"],\"dateCreated\":\"2017-08-14T11:39:00Z\",\"datePublished\":\"2017-08-14T11:39:00Z\",\"dateModified\":\"2019-09-30T11:45:39Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/wncen.com\/p.js"},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/wncen.com\/wp-content\/uploads\/2017\/08\/Ambrosus-New-Header.jpg?fit=1500%2C500","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/posts\/47109","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/users\/516"}],"replies":[{"embeddable":true,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/comments?post=47109"}],"version-history":[{"count":0,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/posts\/47109\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/media\/47204"}],"wp:attachment":[{"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/media?parent=47109"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/categories?post=47109"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wncen.com\/wp-json\/wp\/v2\/tags?post=47109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}